Cholangiocarcinoma (bile duct cancer) is the most common malignancy of the biliary tract, and is increasing in incidence and mortality worldwide. It is usually diagnosed at an advanced stage, at which point the overall prognosis is poor. However, patients with early stage tumors who undergo resection have excellent outcomes. Conversely, lesions of biliary intraepithelial neoplasia (BilIN), a type of cholangiocarcinoma, frequently appear as indeterminate biliary strictures, and because of the difficulty obtaining enough human tissue for histological analysis, clinical diagnosis is often inconclusive. As a result, a large fraction of patients undergo major surgery only to find that the strictures are benign, or wait too long to have curative surgery. The goal of the collaboration is to develop an image-based diagnostic method that uses fluorescently stained probes and a novel endoscopy device to map the probes. With this method, the time to cancer detection could be reduced and the accuracy of diagnosis improved in the following ways: Quantitative mapping of biomarkers of the biliary epithelium is expected to enable detection of molecular changes before structural changes are apparent - it should improve the ability to distinguish cancer from nonlethal disease, and it may be able to identify molecular targets for cancer therapy. High-contrast fluorescence molecular probes can also be used to image the entire indeterminate biliary stricture and can be used to guide biopsy. Because the molecular biology of cholangiocarcinoma is highly heterogeneous, a method of detecting multiple molecular targets is needed. The researchers will use multiple probes known to bind with different cancer targets and, from an existing prototype, will develop a multimodal multispectral scanning fiber endoscope (mmSFE) capable of wide-field imaging of the fluorescence probes. The probes will be optimized and validated, and the mmSFE will be tested with the validated probes in vivo in mice. After the mouse studies, the mmSFE will be tested in pilot human subject trials using topical application of the fluorescence molecular probes and minimally invasive endoscopy. Quantitative tests will also be performed with ex vivo human tissue and phantom pancreatobiliary organs. In vivo and ex vivo images will be compared with pathology findings in order to develop image-based diagnostic tools that can be used alone or combined with tissue and cell samples. Recent research indicates that methods developed for early detection of biliary cancer will be applicable to cancers of other pancreatobiliary organs, specifically cancer of the pancreas, and the fourth leading cause of cancer deaths in the United States. This project has the long-term potential to reduce late-stage diagnoses of pancreatobiliary cancer, thereby improving prognoses, as well as to reduce overdiagnosis of indeterminate biliary strictures, thereby preventing unnecessary major surgery and trauma.

Public Health Relevance

The aim of the project is to develop image-based diagnostic tools that can be used alone or in combination with other procedures to improve rates of early detection of bile duct cancer, and possibly cancers of other organs in the hepato pancreato biliary system (liver, pancreas, bile ducts, and gall bladder). The new tools will help doctors catch bile duct cancer at an earlier stage, when it is more likely that treatments such as surgery and chemotherapy will be effective. These new methods should also improve the accuracy of diagnosis, which would allow doctors to select the most effective method of treatment and reduce the likelihood of unnecessary surgery.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA200007-03
Application #
9308933
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Farahani, Keyvan
Project Start
2015-07-14
Project End
2020-06-30
Budget Start
2017-07-01
Budget End
2018-06-30
Support Year
3
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of Washington
Department
Engineering (All Types)
Type
Biomed Engr/Col Engr/Engr Sta
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Joshi, Bishnu P; Wang, Thomas D (2018) Targeted Optical Imaging Agents in Cancer: Focus on Clinical Applications. Contrast Media Mol Imaging 2018:2015237
Jiang, Yang; Gong, Yuanzheng; Rubenstein, Joel H et al. (2017) Toward real-time quantification of fluorescence molecular probes using target/background ratio for guiding biopsy and endoscopic therapy of esophageal neoplasia. J Med Imaging (Bellingham) 4:024502
Savastano, Luis E; Seibel, Eric J (2017) Scanning Fiber Angioscopy: A Multimodal Intravascular Imaging Platform for Carotid Atherosclerosis. Neurosurgery 64:188-198
Li, Gaoming; Li, Haijun; Duan, Xiyu et al. (2017) Visualizing Epithelial Expression in Vertical and Horizontal Planes With Dual Axes Confocal Endomicroscope Using Compact Distal Scanner. IEEE Trans Med Imaging 36:1482-1490
Duan, Xiyu; Li, Haijun; Wang, Fa et al. (2017) Three-dimensional side-view endomicroscope for tracking individual cells in vivo. Biomed Opt Express 8:5533-5545
Savastano, Luis E; Zhou, Quan; Smith, Arlene et al. (2017) Multimodal laser-based angioscopy for structural, chemical and biological imaging of atherosclerosis. Nat Biomed Eng 1:
Duan, Xiyu; Li, Haijun; Zhou, Juan et al. (2016) Visualizing epithelial expression of EGFR in vivo with distal scanning side-viewing confocal endomicroscope. Sci Rep 6:37315
Joshi, Bishnu P; Zhou, Juan; Pant, Asha et al. (2016) Design and Synthesis of Near-Infrared Peptide for in Vivo Molecular Imaging of HER2. Bioconjug Chem 27:481-94
Rabinsky, Emily F; Joshi, Bishnu P; Pant, Asha et al. (2016) Overexpressed Claudin-1 Can Be Visualized Endoscopically in Colonic Adenomas In Vivo. Cell Mol Gastroenterol Hepatol 2:222-237
Zhou, Quan; Li, Zhao; Zhou, Juan et al. (2016) In vivo photoacoustic tomography of EGFR overexpressed in hepatocellular carcinoma mouse xenograft. Photoacoustics 4:43-54

Showing the most recent 10 out of 12 publications